Pignon JP, le Maitre A, Maillard E, Bourhis J: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009, 92: 4-14. 10.1016/j.radonc.2009.04.014.
Article
PubMed
Google Scholar
Pignon JP, le Maitre A, Bourhis J, et al: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys. 2007, 69: S112-114.
Article
PubMed
Google Scholar
Pingnon JP, Bourhis J, Domenge C, Designe L, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000, 355: 949-955.
Article
Google Scholar
Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998, 16: 1310-1317.
CAS
PubMed
Google Scholar
Baujat B, Audry H, Bourhis J, Chan ATC, Onat H, Chua DTT, et al: Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials in 1753 patient. Inf J Radiat Oncol boil Phys. 2006, 64: 47-56. 10.1016/j.ijrobp.2005.06.037.
Article
CAS
Google Scholar
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003, 349: 2091-2098. 10.1056/NEJMoa031317.
Article
CAS
PubMed
Google Scholar
Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T, et al: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer Phase III trial. J Natl Cancer Inst. 1996, 88: 890-899. 10.1093/jnci/88.13.890.
Article
CAS
PubMed
Google Scholar
Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al: Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004, 22: 69-76. 10.1200/JCO.2004.08.021.
Article
PubMed
Google Scholar
Adelstein DJ, Li Y, Adams GL, Wagner H, Kish JA, Ensley JF, et al: An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003, 21: 92-98. 10.1200/JCO.2003.01.008.
Article
PubMed
Google Scholar
Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al: A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000, 48: 7-16. 10.1016/S0360-3016(00)00663-5.
Article
CAS
PubMed
Google Scholar
Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, et al: Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006, 368: 843-854. 10.1016/S0140-6736(06)69121-6.
Article
PubMed
Google Scholar
Trotti A, Fu KK, Pajak TF, Jones CU, Spencer SA, Phillips TL, et al: Long term outcomes of RTOG 90-03:a comparison of hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005, 63: S70-
Article
Google Scholar
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006, 354: 567-578. 10.1056/NEJMoa053422.
Article
CAS
PubMed
Google Scholar
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010, 11: 21-28. 10.1016/S1470-2045(09)70311-0.
Article
CAS
PubMed
Google Scholar
Curran D, Giralt J, Harari PM, Ang KK, Cohen RB, Kies MS, et al: Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 2007, 25: 2191-2197. 10.1200/JCO.2006.08.8005.
Article
CAS
PubMed
Google Scholar
Caudell JJ, Sawrie SM, Spencer SA, Desmoid RA, Carroll WR, Peters GE, et al: Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetucimab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys. 2008, 71: 676-681. 10.1016/j.ijrobp.2007.10.040.
Article
CAS
PubMed
Google Scholar
Bernier J, Schneider D: Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?. Eur J Cancer. 2007, 43: 35-45. 10.1016/j.ejca.2006.08.035.
Article
CAS
PubMed
Google Scholar
Rowan K: Should Cetuximab replace cisplatin in head and neck cancer?. J Natl Cancer Inst. 2010, 102: 74-75. 10.1093/jnci/djp531.
Article
PubMed
Google Scholar
Grenman R, Chevalier D, Gregoire V, Myers W, Rogers S: Treatment of head and neck cancer in the elderly: European Consensus (panel 6) at the EUFOS congress in Vienna 2007. Eur Arch Otorhinolaryngol. 2010,
Google Scholar
Huang SH, O'Sullivan B, Waldron J, Lockwood G, Bayley A, Kim J, Cummings B, et al: Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys. 2010,
Google Scholar
Gregoire V, Eisbruch A, Hamoir M, Levendag P: Propsal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006, 79: 15-20. 10.1016/j.radonc.2006.03.009.
Article
PubMed
Google Scholar
Levendag P, Braaksma M, Coche E, Van der Est P, Hamoir M, Muller K, et al: Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American academy of otolaryngology-head and neck surgery. Int J Radiat Oncol Biol Phys. 2004, 58: 113-123. 10.1016/S0360-3016(03)01453-6.
Article
PubMed
Google Scholar
Poon I, Fischbein N, Lee N, Akazawa P, Xia P, Quivey J, et al: A population-based atlas and clinical target volume for the head-and-neck lymph nodes. Int J Radiat Oncol Biol Phys. 2004, 59: 1301-1311. 10.1016/j.ijrobp.2004.01.038.
Article
PubMed
Google Scholar
Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun R, et al: Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol. 2008, 26: 5518-5523. 10.1200/JCO.2007.15.0102.
Article
CAS
PubMed
Google Scholar
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RA, Rubinstein L, et al: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000, 92: 205-216. 10.1093/jnci/92.3.205.
Article
CAS
PubMed
Google Scholar
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Ass. 1958, 53: 457-481. 10.2307/2281868.
Article
Google Scholar
Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM, Haddad RI, TAX 324 Study Group: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007, 357: 1705-15. 10.1056/NEJMoa070956.
Article
CAS
PubMed
Google Scholar
Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL, EORTC 24971/TAX 323 Study Group: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007, 357: 1695-704. 10.1056/NEJMoa071028.
Article
CAS
PubMed
Google Scholar
Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, et al: Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001, 50: 1161-1171. 10.1016/S0360-3016(01)01544-9.
Article
CAS
PubMed
Google Scholar
Cooper JS, Farnan NC, Asbell SO, Rotman M, Marcial V, Fu KK, et al: Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer. 1996, 77: 1905-1911. 10.1002/(SICI)1097-0142(19960501)77:9<1905::AID-CNCR22>3.0.CO;2-2.
Article
CAS
PubMed
Google Scholar
Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, et al: Prognostic factors in oropharyngeal cancer - analysis of 627 cases receiving definitive radiotherapy. Acta Oncol. 2009, 48: 1026-1033. 10.1080/02841860902845839.
Article
PubMed
Google Scholar
Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, et al: Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys. 2008, 70: 353-360. 10.1016/j.ijrobp.2007.06.024.
Article
PubMed
Google Scholar
Yurut-Caloglu V, Caloglu M, Turan FN, Ibis K, Karagol H, Kocak Z, et al: The better performance status, the better outcome: laryngeal carcinoma treated with definitive radiotherapy. J Otolaryngol Head neck Surg. 2008, 37: 799-806.
PubMed
Google Scholar
Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al: Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004, 22: 69-76. 10.1200/JCO.2004.08.021.
Article
PubMed
Google Scholar
Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao JK, Stenson KM, et al: Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2006, 64: 382-391. 10.1016/j.ijrobp.2005.07.005.
Article
PubMed
Google Scholar
Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, et al: Salvage re-irradiation for recurrent head and neck cancer. J Radiat Oncol Biol Phys. 2007, 68: 731-740. 10.1016/j.ijrobp.2006.12.055.
Article
Google Scholar
De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A, et al: Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol. 1998, 16: 3556-3562.
CAS
PubMed
Google Scholar
Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, et al: IMRT reirradiation of head and neck cancer - disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 73: 399-409.
Roh KW, Jang JJ, Kim MS, Sun DI, Kim BS, Jung SL, et al: Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2009, 74: 1348-1355. 10.1016/j.ijrobp.2008.10.013.
Article
PubMed
Google Scholar
Clavel S, Nguyen D, Despres P, Fortin B, Coulombe G, Donath D, et al: Higher dose per fraction and shorter overall treatment time using intensity-modulated radiation therapy versus conventional radiation therapy with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma: a comparison of toxicity and efficacy. J Clin Oncol. 2009, 27: 15s-10.1200/JCO.2008.21.7695.
Article
Google Scholar